Revolution Medicines, Inc. RVMD Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -76.7%-18.6pp | -58.1%+2.7pp | -60.8%-14.1pp | -46.6%-9.9pp | -36.7%-7.3pp | |
| Return on invested capital | -89.6%-17.2pp | -72.4%-3.1pp | -69.4%-10.1pp | -59.3%-12.9pp | -46.4%-1.5pp | |
| Liquidity | ||||||
| Current ratio | 6.8×-0.3× | 7.1×-0.9× | 8.1×-3.7× | 11.8×-1.7× | 13.5×-0.7× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $7.57-11.8% | $8.58+1.7% | $8.44-14.7% | $9.89-10.4% | $11.05-18.2% | |
| Valuation | ||||||
| Market capitalization | $19.27B+25.2% | $15.4B+76.4% | $8.73B+17.1% | $7.46B+13.4% | $6.57B-18.7% | |
| Price / book | 12.8×+3.4× | 9.4×+4.0× | 5.5×+1.5× | 4×+0.8× | 3.2×-0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Revolution Medicines, Inc.'s ratios come from?
- Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.